A7GNS3

PR
Gene name
trhO
Protein name
tRNA uridine(34) hydroxylase
Names
tRNA hydroxylation protein O
Species
Bacillus cytotoxicus (strain DSM 22905 / CIP 110041 / 391-98 / NVH 391-98)
KEGG Pathway
bcy:Bcer98_1464
EC number
Protein Class

Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

19-155 (Predicted disordered autoinhibitory region) PR

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

References

Autoinhibited structure

Activated structure

1 structures for A7GNS3

Entry ID Method Resolution Chain Position Source
AF-A7GNS3-F1 Predicted AlphaFoldDB

No variants for A7GNS3

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for A7GNS3

No associated diseases with A7GNS3

3 regional properties for A7GNS3

Type Name Position InterPro Accession
domain Rhodanese-like domain 117 - 221 IPR001763
domain Rhodanase, C-terminal 224 - 290 IPR022111
domain tRNA uridine(34) hydroxylase, N-terminal 7 - 97 IPR040503

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

1 GO annotations of molecular function

Name Definition
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from each of two donors, and molecular oxygen is reduced or incorporated into a donor.

1 GO annotations of biological process

Name Definition
tRNA modification The covalent alteration of one or more nucleotides within a tRNA molecule to produce a tRNA molecule with a sequence that differs from that coded genetically.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAIKKPYRVL LYYMYTTIEN PEEFAAEHLQ FCNSLELKGR ILVAKEGING TASGTTEQTE
70 80 90 100 110 120
KYMEAMKNDP RFAGIVFKVD EADGHAFKKM HVRPRSELVT LRLEDDINPK ELTGKYLEPK
130 140 150 160 170 180
EFYEAMQQEE TIVIDARNDY EYDLGHFRGA IKPEIKSFRE LPNWIKENKE VLEGKKILTY
190 200 210 220 230 240
CTGGIRCEKF SGWLVREGFE DVSQLHGGIV TYGKDPEVQG ELWDGQCYVF DERIAVPVNQ
250 260 270 280 290 300
KEHVIVGRDH FTNEPCERYV NCANPECNKQ ILCSEENEAK YLRACSHECR VHPRNRYVKE
310 320
HELTEEQVAA ALEKIEAENQ VKLG